Abstract

Although we now routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. Here, we developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin‐like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). The resulting maps recapitulate known protein features and confidently identify pathogenic variation. Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could ultimately map functional variation for all human disease genes.

Highlights

  • We routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact

  • We describe a framework for comprehensively mapping functional missense variation, organized into six stages: (i) mutagenesis; (ii) generation of a variant library; (iii) selection of functional variants; (iv) readout of the selection results and analysis to produce an initial sequence-function map; (iv) computational analysis to impute missing values; and (vi) computational analysis to refine measured values via machine learning

  • We scaled up a previous mutagenesis protocol (Seyfang & Huaqian Jin, 2004) to develop Precision OligoPool based Code Alteration (POPCode), which yields random codon replacements

Read more

Summary

Introduction

We routinely sequence human genomes, we can confidently identify only a fraction of the sequence variants that have a functional impact. We developed a deep mutational scanning framework that produces exhaustive maps for human missense variants by combining random codon mutagenesis and multiplexed functional variation assays with computational imputation and refinement. We applied this framework to four proteins corresponding to six human genes: UBE2I (encoding SUMO E2 conjugase), SUMO1 (small ubiquitin-like modifier), TPK1 (thiamin pyrophosphokinase), and CALM1/2/3 (three genes encoding the protein calmodulin). Assays potentially amenable to deep mutational scanning are already available for 57% of human disease genes, suggesting that DMS could map functional variation for all human disease genes.

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.